FIELD: chemistry.
SUBSTANCE: claimed is group of the inventions, relates to application of compound of structural formula
(arbecacin)
as reading inductor for induction of reading of premature stop-codon, formed as a result of nonsense-mutations, and to medication, including said inductor, for treatment of genetic disease, caused by nonsense-mutations (for instance, Duchenne muscular dystrophy).
EFFECT: realisation of the claimed purpose.
4 cl, 10 dwg, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING FUNCTIONAL PROTEIN FROM DNA HAVING NONSENSE MUTATIONS, AND TREATING ASSOCIATED DISORDERS | 2007 |
|
RU2462246C2 |
| METHODS OF DOSING ORALLY ACTIVE 1,2,4-OXADIAZOLE FOR NONSENSE MUTATION SUPPRESSIVE THERAPY | 2007 |
|
RU2462247C2 |
| MEANS FOR TREATMENT OF VIOLATIONS INVOLVING RIANODIN RECEPTORS MODULATION | 2013 |
|
RU2644350C2 |
| CODON-OPTIMISED CDNA CODING HUMAN DYSFERLIN, GENETICALLY ENGINEERED CONSTRUCT, RECOMBINANT ADENOVIRUS AND PHARMACEUTICAL COMPOSITION FOR TREATING DYSFERLINOPATHIES | 2012 |
|
RU2527073C2 |
| METHOD OF TREATMENT OF PATIENTS WITH DUCHENNE'S-BECKER'S MYODYSTROPHY DISEASE | 1998 |
|
RU2173144C2 |
| NITROGEN OXIDE-RELEASING COMPOUNDS | 2007 |
|
RU2560144C2 |
| METHOD OF PRODUCING MOUSE MODEL FOR STUDYING DUCHENNE MUSCULAR DYSTROPHY AND VERSIONS OF ITS THERAPY | 2023 |
|
RU2815936C1 |
| PHYTOECDYSONES AND THEIR DERIVATIVES FOR USE IN TREATMENT OF PULMONARY DYSFUNCTIONS | 2020 |
|
RU2812022C2 |
| APPLICATION OF NITROOXYDERIVATIVE DRUG FOR TREATING MUSCULAR DYSTROPHY | 2007 |
|
RU2429828C2 |
| TRIAZOLES FOR REGULATION OF INTRACELLULAR CALCIUM HOMEOSTASIS | 2017 |
|
RU2753509C2 |
